ROSENBLUM SILVERMAN SUTTON S F INC /CA - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 185 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROSENBLUM SILVERMAN SUTTON S F INC /CA ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$1,321,000
-66.6%
23,665
-84.1%
0.60%
-54.0%
Q3 2018$3,951,000
-34.2%
148,370
-6.7%
1.31%
-37.2%
Q2 2018$6,006,000
+46.9%
159,010
+27.0%
2.08%
+43.1%
Q1 2018$4,089,000
-34.6%
125,210
-2.5%
1.46%
-35.2%
Q4 2017$6,253,000
-10.5%
128,460
-0.7%
2.25%
-15.3%
Q3 2017$6,988,000
+16.7%
129,330
+21.3%
2.65%
+10.9%
Q2 2017$5,989,000
+54.7%
106,620
+7.9%
2.39%
+46.0%
Q1 2017$3,871,00098,7851.64%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 232,952$5,498,0005.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,673,727$86,700,0003.41%
Redmile Group, LLC 1,466,537$34,610,0003.31%
SECTORAL ASSET MANAGEMENT INC 1,229,382$29,013,0003.00%
HARVEY CAPITAL MANAGEMENT INC 206,530$4,874,0002.44%
Marcus Capital, LLC 75,150$1,774,0001.87%
Cormorant Asset Management, LP 396,000$9,346,0001.32%
Rail-Splitter Capital Management, LLC 221,414$5,225,0001.25%
Temasek Holdings (Private) Ltd 6,583,568$155,372,0001.21%
EMERALD MUTUAL FUND ADVISERS TRUST 636,526$15,022,0000.84%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders